Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.”

Read more

Beyond the Data

In his “Beyond the Data” columns, Dr. Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Drew Altman, KFF President and CEP is quoted on this card saying, "People are bewildered by a supercharged and polarized debate about vaccines and no longer know where to turn for scientific information they can rely on ... The vaccines are not the culprit—we and the state of our politics and the distrust in science and our scientific institutions they breed are."

The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

In a new “Beyond the Data” column, Dr. Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for the facts.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

211 - 220 of 324 Results

  • How Primary-Care Physicians Are Handling the Influx of Newly Insured

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Kaiser’s President Drew Altman is joined by The Commonwealth Fund's President David Blumenthal to discuss the impact of the Affordable Care Act’s coverage expansion on the primary care delivery system.

  • Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.

  • Will GOP Candidates’ Positions on Obamacare Matter in Crowded Field?

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman analyzes the politics of Republican Affordable Care Act replacement plans and the challenges all Republican candidates will face distinguishing themselves from others on the ACA in a crowded primary field.

  • What Post-Katrina New Orleans Shows About Urban and Race Issues

    From Drew Altman

    Drew Altman discusses a growing racial divide in the city about perceptions of economic opportunity for blacks and whites and what progress and challenges in New Orleans may mean for urban America in this column for The Wall Street Journal's Think Tank.

  • At CMS, the Mission Is Broader Than Medicare and Medicaid

    From Drew Altman

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses whether the Centers for Medicare and Medicaid Services' broad new responsibilities implementing the Affordable Care Act and a more proactive approach to Medicare payment signals that it’s time for (another) name change.

  • The Connection Between Health Coverage and Income Security

    From Drew Altman

    In this column in The Wall Street Journal's Think Tank, Drew Altman shows how expanding health coverage and improving economic security for working Americans are connected even though they are often part of separate policy debates.

  • How to Think About Higher Growth in Health-Care Spending

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explains that just as we should not have expected historically low rates of health spending increases to continue, we should not dramatize a return to higher rates in coming years.

  • Medicare and Medicaid at 50 Years: Perspectives of Beneficiaries, Health Care Professionals and Institutions, and Policy Makers

    From Drew Altman

    In this article for the Journal of the American Medical Association (JAMA), Drew Altman and former U.S. Senate Majority Leader William Frist examine the roles the Medicaid and Medicare play in the health system today from the perspectives of the public and beneficiaries, providers, and policymakers, and discusses the challenges they face in the future. The article is accompanied by an audio interview with Altman and Frist, who is a member of the Foundation’s board of trustees.

  • A Little-Noticed Win in Global HIV Treatment

    From Drew Altman

    This was published as a Wall Street Journal Think Tank column on Jul7 27, 2015. Many Americans are skeptical about foreign aid because they believe a large share of U.S. assistance is lost to corruption.